- Home
- IMNM vs GCT Comparison
IMNM vs GCT Comparison
Compare IMNM & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- GCT
- Stock Information
- Founded
- IMNM 2006
- GCT 2019
- Country
- IMNM United States
- GCT United States
- Employees
- IMNM N/A
- GCT N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- GCT Catalog/Specialty Distribution
- Sector
- IMNM Health Care
- GCT Consumer Discretionary
- Exchange
- IMNM Nasdaq
- GCT Nasdaq
- Market Cap
- IMNM 945.8M
- GCT 798.3M
- IPO Year
- IMNM 2020
- GCT 2022
- Fundamental
- Price
- IMNM $9.01
- GCT $30.06
- Analyst Decision
- IMNM Strong Buy
- GCT Buy
- Analyst Count
- IMNM 8
- GCT 2
- Target Price
- IMNM $24.75
- GCT $24.00
- AVG Volume (30 Days)
- IMNM 1.0M
- GCT 1.1M
- Earning Date
- IMNM 11-12-2025
- GCT 11-06-2025
- Dividend Yield
- IMNM N/A
- GCT N/A
- EPS Growth
- IMNM N/A
- GCT 19.25
- EPS
- IMNM N/A
- GCT 3.31
- Revenue
- IMNM $12,589,000.00
- GCT $1,193,610,000.00
- Revenue This Year
- IMNM N/A
- GCT $4.65
- Revenue Next Year
- IMNM $154.73
- GCT $4.94
- P/E Ratio
- IMNM N/A
- GCT $9.26
- Revenue Growth
- IMNM 16.74
- GCT 21.20
- 52 Week Low
- IMNM $5.15
- GCT $11.17
- 52 Week High
- IMNM $16.73
- GCT $34.50
- Technical
- Relative Strength Index (RSI)
- IMNM 43.25
- GCT 58.40
- Support Level
- IMNM $9.01
- GCT $25.15
- Resistance Level
- IMNM $9.63
- GCT $31.45
- Average True Range (ATR)
- IMNM 0.71
- GCT 1.36
- MACD
- IMNM -0.07
- GCT 0.16
- Stochastic Oscillator
- IMNM 17.38
- GCT 77.86
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.